Risperdal Claims for Gynecomastia and Illegal Marketing
Risperdal lawsuits blame Johnson & Johnson for hiding serious side effects, including gynecomastia.
A 2019 Risperdal lawsuit ended in an $8 billion verdict against the company. Johnson & Johnson had previously agreed to two Risperdal settlements for $181 million and $2.2 billion to resolve charges that it had promoted the drug for off-label uses.
About TriMark
TriMark Legal Funding provides Risperdal pre settlement funding to injured plaintiffs nationwide.
This post originally appeared here: https://www.drugwatch.com/risperdal/lawsuits/
Click here to see the full original article.